APA (7th ed.) Citation

İ, D., A, T. C., FT, A., T, İ., & S, G. Y. (2026). CXCL12 rs1801157 Polymorphism Is Associated with Antiatherogenic Lipoprotein Subfraction Profile Independent of Coronary Artery Disease Risk in a Turkish Population: A Case-Control Study. Journal of clinical medicine, 15(11), . https://doi.org/10.3390/jcm15114206

Chicago Style (17th ed.) Citation

İ, Deniz, Türer Cabbar A, Akdeniz FT, İsbir T, and Güleç Yılmaz S. "CXCL12 Rs1801157 Polymorphism Is Associated with Antiatherogenic Lipoprotein Subfraction Profile Independent of Coronary Artery Disease Risk in a Turkish Population: A Case-Control Study." Journal of Clinical Medicine 15, no. 11 (2026). https://doi.org/10.3390/jcm15114206.

MLA (9th ed.) Citation

İ, Deniz, et al. "CXCL12 Rs1801157 Polymorphism Is Associated with Antiatherogenic Lipoprotein Subfraction Profile Independent of Coronary Artery Disease Risk in a Turkish Population: A Case-Control Study." Journal of Clinical Medicine, vol. 15, no. 11, 2026, https://doi.org/10.3390/jcm15114206.